ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Lab-Grown Human-Chicken Hybrid Embryos Are No ‘Frankenfowl’ – Live Science

Continue reading

2018-05-29 Michael Zand NEWS

Fujifilm Expands Fill/Finish Services To Include Late Phase Gene Therapies And Vaccines – Pharmaceutical Processing

Fujifilm Expands Fill/Finish Services To Include Late Phase Gene Therapies And VaccinesPharmaceutical ProcessingFujifilm Diosynth Biotechnologies (Fujifilm), a contract development and manufacturing organization (CDMO) with experience in recombinant bi… Continue reading

2018-05-29 Michael Zand NEWS

Mesoblast Partners With Cartherics to Develop ‘off-the-shelf’ Cell-based Immunotherapies for Solid CancersRelapsed … – Markets Insider


Live Science

Lab-Grown Human-Chicken Hybrid Embryos Are No ‘Frankenfowl’
Live Science
Scientists recently combined human stem cells with chicken embryos, but that doesn’t mean the researchers are breeding flocks of “frankenfowl.” Rather, the scientists are looking closely at how those embryonic cells organize themselves, to better …
Human Embryonic Stem Cells Assay Instrument Sales Market Cost Analysis, Revenue and Gross Margin Analysis with …Pharmaceuticals News

all 2 news articles »

Continue reading

2018-05-29 Michael Zand NEWS

Mesoblast Partners With Cartherics to Develop ‘off-the-shelf’ Cell-based Immunotherapies for Solid Cancers – GlobeNewswire (press release)

Mesoblast Partners With Cartherics to Develop ‘off-the-shelf’ Cell-based Immunotherapies for Solid CancersRelapsed …
Markets Insider
NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR–T cells …

Continue reading

2018-05-29 Michael Zand NEWS

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment – Technology Networks

Mesoblast Partners With Cartherics to Develop ‘off-the-shelf’ Cell-based Immunotherapies for Solid Cancers
GlobeNewswire (press release)
NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR–T cells …

and more »

Continue reading

2018-05-29 Michael Zand NEWS

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment – Technology Networks


Technology Networks

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment
Technology Networks
Newborn Elianna is held by her mother, Nichelle Obar, and father, Chris Constantino. Elianna was born at UCSF Benioff Children’s Hospital San Francisco after receiving an in utero stem cell transplant to treat a lethal form of thalassemia. Credit: Noah …

Continue reading

2018-05-29 Michael Zand NEWS

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment – Technology Networks


Technology Networks

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment
Technology Networks
Newborn Elianna is held by her mother, Nichelle Obar, and father, Chris Constantino. Elianna was born at UCSF Benioff Children’s Hospital San Francisco after receiving an in utero stem cell transplant to treat a lethal form of thalassemia. Credit: Noah …
UCSF performs first-ever transplant in a fetusThe Mercury News

all 3 news articles »

Continue reading

2018-05-29 Michael Zand NEWS

Spark’s Gene Therapy For Hemophilia B Looks To Change Up The Game – Seeking Alpha


Technology Networks

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment
Technology Networks
Newborn Elianna is held by her mother, Nichelle Obar, and father, Chris Constantino. Elianna was born at UCSF Benioff Children’s Hospital San Francisco after receiving an in utero stem cell transplant to treat a lethal form of thalassemia. Credit: Noah …

Continue reading

2018-05-29 Michael Zand NEWS
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Seeking Alpha

Spark’s Gene Therapy For Hemophilia B Looks To Change Up The Game
Seeking Alpha
Spark Therapeutics posts positive phase 1/2 results treating patients with Hemophilia B using SPK-9001. Pfizer is expected to lead the rest of the development for the Hemophilia B candidate SPK-9001 by this summer since it is partnered with Spark.